title: High dosage of aripiprazole-induced dysphagia.
abstract: BACKGROUND
  Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics.
  
  
  METHODS
  We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment.
  
  
  RESULTS
  This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case.
  
  
  CONCLUSIONS
  Aripiprazole-induced dysphagia is rare, and it is important to be aware that it does occur with high-dosage treatment.
authors.affiliation: Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, LuKang, Taiwan.
authors.forename: Ta-Wei
authors.initials: TW
authors.lastname: Lin
authors.forename: Bo-Shyan
authors.initials: BS
authors.lastname: Lee
authors.forename: Yi-Cheng
authors.initials: YC
authors.lastname: Liao
authors.forename: Nan-Ying
authors.initials: NY
authors.lastname: Chiu
authors.forename: Wen-Yu
authors.initials: WY
authors.lastname: Hsu
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D003680:Deglutition Disorders / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole